Investor Notice: Robbins LLP Informs Investors of the Grail, Inc. Class Action LawsuitRobbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grail, Inc. (
NASDAQ: GRAL) securities between May 13, 2025, and February 19, 2026. Grail, Inc. describes itself as a commercial stage healthcare company with a focus on early cancer detection through screening methodology.
GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law FirmThe Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of GRAIL, Inc. (“GRAIL” or “the Company”) (
NASDAQ: GRAL) for violations of the securities laws.
Kaplan Fox Alerts Investors of Grail, Inc. (GRAL) to an Investigation of Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kaplan Fox Alerts Investors of Grail, Inc. (GRAL) to an Investigation of Potential Securities Law ViolationsNEW YORK, NY - February 27, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
Grail, Inc. (NASDAQ: GRAL) Shareholder Investigation - Kaplan Fox Reviewing Potential ClaimsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Grail, Inc. (NASDAQ: GRAL) Shareholder Investigation - Kaplan Fox Reviewing Potential ClaimsNEW YORK, NY - February 26, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
Grail, Inc. (GRAL) Securities Investigation Announced by Kaplan Fox & Kilsheimer LLPNEW YORK, NY - February 25, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
Grail, Inc. (GRAL) Securities Investigation Announced by Kaplan Fox & Kilsheimer LLPSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Grail Investor ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Grail Investor ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law ViolationsNEW YORK, NY - February 24, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
GRAL ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law ViolationsNEW YORK, NY - February 23, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grail, Inc. (“Grail” or the “Company”) (Nasdaq: GRAL).
GRAL ALERT: Kaplan Fox is Investigating Grail, Inc. (NASDAQ: GRAL) for Potential Securities Law ViolationsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Grail Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Grail, Inc. (
NASDAQ: GRAL). The investigation focuses on Grail’s executive officers and whether investor losses may be recovered under federal securities laws.
Strategic Buy Lights Up This Biotech Stock: Time to Invest?Life sciences company Illumina Inc. (
NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.
